Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.56 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.56 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.56 |
| ▸ | PSMA1 | P25786 | 1/20 | 0.56 |
| ▸ | PSMA2 | P25787 | 1/20 | 0.56 |
| ▸ | PSMA3 | P25788 | 1/20 | 0.56 |
| ▸ | PSMA4 | P25789 | 1/20 | 0.56 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.56 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.56 |
| ▸ | PSMA5 | P28066 | 1/20 | 0.56 |
| ▸ | PSMB4 | P28070 | 1/20 | 0.56 |
| ▸ | PSMB6 | P28072 | 1/20 | 0.56 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.56 |
| ▸ | PSMB10 | P40306 | 1/20 | 0.56 |
| ▸ | PSMB3 | P49720 | 1/20 | 0.56 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22757712 | 0.94 | CYP2C19 (0.58) | CYP2C19CYP1A2CYP2D6MAPTPSMB11 | |
| SCHEMBL10207505 | 0.88 | CYP2C19 (0.59) | CYP2C19CYP1A2CYP2D6MAPTPSMB11 | |
| SCHEMBL8336741 | 0.86 | CYP2C19 (0.57) | CYP2C19CYP1A2CYP2D6MAPTPSMB11 | |
| SCHEMBL14500985 | 0.85 | CYP2C19 (0.60) | CYP2C19CYP1A2CYP2D6MAPTGAA | |
| SCHEMBL21583802 | 0.85 | CYP2C19 (0.56) | CYP2C19CYP1A2CYP2D6MAPTPSMB11 | |
| SCHEMBL10707490 | 0.84 | CYP2C19 (0.63) | CYP2C19CYP1A2CYP2D6MAPTPSMB11 | |
| SCHEMBL13631419 | 0.84 | CYP2C19 (0.69) | CYP2C19CYP1A2CYP2D6MAPTPSMB11 | |
| SCHEMBL13444578 | 0.83 | PSMB11 (0.57) | CYP2C19CYP1A2CYP2D6MAPTPSMB11 | |
| SCHEMBL16215617 | 0.82 | CYP2C19 (0.60) | CYP2C19CYP1A2CYP2D6MAPTPSMB11 | |
| SCHEMBL6960703 | 0.82 | CYP2C19 (0.60) | CYP2C19CYP1A2CYP2D6MAPTPSMB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542283-B2 | Synthesis of peptide borate ester compound and use thereof | JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) | 2023-01-03 | — | — | US | disclosed |
| US-11542283-B2 | Synthesis of peptide borate ester compound and use thereof | JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) | 2023-01-03 | — | — | US | disclosed |
| EP-4006012-A1 | PROTEASOME INHIBITORS AND USES THEREOF | Cornell University (US) | 2022-06-01 | — | — | EP | disclosed |
| US-11207370-B2 | Peptidomimetics for the treatment of coronavirus and picornavirus infections | EMORY UNIVERSITY (US) | 2021-12-28 | — | — | US | disclosed |
| EP-3362754-B1 | PROTEASOME INHIBITORS AND USES THEREOF | UNIV CORNELL (US) | 2021-12-22 | — | — | EP | disclosed |
| US-20210214377-A1 | SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF | JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) | 2021-07-15 | — | — | US | disclosed |
| US-20210214377-A1 | SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF | JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) | 2021-07-15 | — | — | US | disclosed |
| EP-3805237-A1 | SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CN) | 2021-04-14 | — | — | EP | disclosed |
| EP-3805237-A1 | SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CN) | 2021-04-14 | — | — | EP | disclosed |
| US-20210008150-A1 | PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS | EMORY UNIVERSITY | 2021-01-14 | — | — | US | disclosed |
| WO-2019228299-A1 | SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND | 江苏正大丰海制药有限公司 (CN) | 2019-12-05 | — | — | WO | disclosed |
| WO-2017066763-A1 | PROTEASOME INHIBITORS AND USES THEREOF | CORNELL UNIVERSITY (US) | 2017-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214377-A1 | SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF | SEM1, VIP, PSMB11 | CYP2C19 2389/4885CYP1A2 4739/4885CYP2D6 3629/4885 |
| US-20210008150-A1 | PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS | ACE2, SARS1, VIP | CYP2C19 3053/4885CYP1A2 2986/4885CYP2D6 3662/4885 |
| US-11207370-B2 | Peptidomimetics for the treatment of coronavirus and picornavirus infections | ACE2, SARS1, VIP | CYP2C19 3053/4885CYP1A2 2986/4885CYP2D6 3662/4885 |
| US-11542283-B2 | Synthesis of peptide borate ester compound and use thereof | SEM1, VIP, PSMB11 | CYP2C19 2389/4885CYP1A2 4739/4885CYP2D6 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.